[1] |
QI Linling, LIU Shourong.
Research progress of tenofovir alafenamide in blocking mother-to-child transmission of hepatitis B virus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 578-582.
|
[2] |
ZHANG Lei, XIAO Xingpeng, DING Huang .
Silencing ZKSCAN3 gene expression aggravates lung injury induced by LPS in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 164-170.
|
[3] |
MA A'xue, LU Xiaohong, DONG Bo, WANG Dong.
Research progress of exosomal miRNA in skin wound healing and regeneration
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 919-924.
|
[4] |
WU Shuai, YANG Jun, ZHENG Yun.
Dual role of miRNA in breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 814-821.
|
[5] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[6] |
ZHOU Guangchen, LIU Yixi, ZHENG Yun.
Colorectal cancer and microRNA: research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 575-587.
|
[7] |
ZHANG Jianmin, LENG Yufang, LIU Xin, REN Yixing, SHI Yajing, CHEN Feng.
Research progress on the mechanism of miRNA in intestinal ischemia-reperfusion injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 332-340.
|
[8] |
TAO Chengjing, LIU Shourong, CHENG Xiaoxian, HU Jiannv, BAI Xiuli, ZHANG Suying, ZHAO Chun, ZUO Zhongbao.
Effects of different postpartum withdrawal time of tenofovir on hepatitis B virus markers, virology and biochemical indexes
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(10): 1146-1152.
|
[9] |
LU Chenyu, YANG Jun, LIU Yixi, ZHENG Yun.
Function and regulation of miRNAs associated with Parkinson's disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 775-783.
|
[10] |
ZENG Chuanli, HU Airong, HU Yaoren, YUAN Gang, ZHU Dedong, SHI Xiaojun.
Clinical effect of entecavir combined with probiotics on treatment of patients with hepatitis B cirrhosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 796-801.
|
[11] |
ZHOU Hongping, YANG Xingxin, ZHUANG Rangxiao, SHAO Yidan, XI Jianjun, LIAO Li, REN Bailu, WANG Pingping, YU Shuying, SHI Tingting.
Effects of activated carbon N-acetylcysteine sustained-release microcapsule on miRNA of non-alcoholic fatty liver disease in young rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(3): 263-270.
|
[12] |
YUAN Gang, HU Airong, HU Yaoren, ZENG Chuanli, ZHU Dedong, SHI Xiaojun.
Clinical efficacy and long-term prognosis of entecavir and adefovir dipivoxil in the treatment of compensatory hepatitis B cirrhosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(2): 170-174.
|
[13] |
PAN Xiaoqiu, ZHAI Hongjun, LI Lihui, BAN Yaolin.
Study on differential expression of the mi-RNA in the deep second degree burns
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1321-1328.
|
[14] |
LUO Shengyong, JIA Dewu, LI Xiaoyi, DAI Xiangrong.
Study on the protective mechanism of anti-platelet thrombolysin against cerebral ischemia reperfusion injury in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(10): 1109-1115.
|
[15] |
CHEN Yonghua, CAO Qunfen, HONG Qiongyi, WANG Shumin.
Effect of tenofovir disoproxil fumarate on serum FGF-23,β2-MG,Cys-C and RBP level in patients with chronic hepatitis B
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(7): 799-804.
|